News

FDA votes against overall benefit/risk profile of GSK's multiple myeloma candidate at proposed dosage
Drugmaker GSK said on Friday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had voted against ...
Fierce Biotech2d
GSK telegraphs 'very limited number' of job cuts amid R&D investment spree
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
US FDA approves pre-filled version of GSK's shingles vaccine
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
Fierce Pharma13h
FDA advisors spurn GSK’s Blenrep comeback dreams on safety, trial concerns
On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...
GSK slides Tuesday, underperforms market
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
GSK's Linerixibat Poised To Address Substantial Unmet Need For The Treatment Of Pruritus Associated With Primary Biliary Cholangitis, According To Spherix Global Insights
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
Fierce Pharma2d
As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting
GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...
Medical Dialogues23h
GSK Shingrix approved by USFDA in prefilled syringe presentation
London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...